Related Experiment Videos
Sudden death. Evaluation and prevention
1Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California.
Insights
Assessing sudden cardiac death risk involves various tests. Management increasingly favors non-drug treatments like implantable cardioverter-defibrillators (ICDs) over medications.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Sudden death presents a complex clinical challenge.
- Risk stratification requires diverse assessment methods.
Purpose of the Study:
- To outline the current clinical approach to sudden death risk assessment.
- To review management strategies for patients at risk.
Main Methods:
- Utilizes a combination of invasive and noninvasive diagnostic modalities.
- Includes Holter monitoring, ejection fraction assessment, signal-averaged ECG, and electrophysiology studies.
Main Results:
- Patient management integrates antiarrhythmic drugs, surgery, catheter ablation, and implantable cardioverter-defibrillators (ICDs).
- A growing trend favors non-pharmacologic interventions, particularly device-based therapies.
Conclusions:
- Effective management hinges on understanding individual pathophysiology and clinical factors.
- Device therapy is increasingly central to preventing sudden cardiac death.
Abstract:
The clinical approach to sudden death involves the assessment of risk in a heterogeneous group of patients via a combination of modalities, both invasive and noninvasive. These include Holter monitoring, assessment of left ventricular ejection fraction, signal-averaged high gain ECG, and cardiac electrophysiology study. The management of these patients requires a better understanding of the underlying pathophysiology and clinical factors in the individual patient and is based on an approach using antiarrhythmic agents, surgery, catheter ablation techniques, and the AICD. The current trend appears to be more toward nonpharmacologic methods, especially the use of devices.